Barely Significant
← all excerpts

A Systematic Literature Review of the Epidemiology, Health-Related Quality of Life Impact, and Economic Burden of Immunoglobulin A Nephropathy.

J Health Econ Outcomes Res · 2021 · PMC8410133 · PMID 34692885

2
hedged sentences
closest p
boldest claim

The sentences

an increasing trendno p-value reported
30,38,41 One US study found an increasing trend in IgAN incidence, from 0.1/100 000 person-years in 2000 to 1.6/100 000 person-years in 2011. 31 Three US-based studies reported IgAN rates among adult and pediatric patients with GN by race, finding higher rates in Asian Americans (2.75/100 000 person-years) than any other race (ranging from 0.1 in African Americans to 0.96 in Hispanic individuals). 31 There were no US publications that reported on the prevalence of IgAN.

also in 63,971 other papers

may be significantno p-value reported
The tendency of IgAN to be diagnosed at later CKD stages in the United States suggests that kidney damage may be significant before treatment can begin, implying the need for increased awareness and urine screening for proteinuria.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.